SEMABIZ, Inc.

バイオテクノロジー市場におけるAl – 2029年までの世界予測

AI in Biotechnology Market – Global Forecast to 2029

バイオテクノロジー市場におけるAl – 機能 (医薬品設計と最適化、バイオマーカー、SAR、臨床試験設計、データ評価、RWE、在庫、サプライチェーン、物流、上市、価格設定、患者エンゲージメント、有害事象)、およびエンドユーザー – 2029年までの世界予測
Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User – Global Forecast to 2029

The global AI in biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period.

バイオテクノロジーにおける世界のAI市場は、予測期間中に19.1%という高いCAGRで、2024年の32億3,000万米ドルから2029年までに77億5,000万米ドルに達すると予測されています。

バイオテクノロジー市場におけるAl – 2029年までの世界予測
ai-in-biotechnology-market-Overview

NVIDIA Corporation (US), Illumina, Inc. (US), Exscientia plc (UK), Schrödinger, Inc. (US), Recursion Pharmaceuticals, Inc.  (US),  SOPHiA GENETICS (Switzerland), Predictive Oncology. (US), Deep Genomics. (Canada), ), Data4Cure, Inc. (US), Genoox (US), BenevolentAI (US), and DNAnexus, Inc. (US) are some of the key players in the AI in biotechnology market.

This report provides insights on:

Analysis of key drivers: (growing cross-industry collaborations and partnerships, growing need to reduce the time and cost of drug discovery and development, rising adoption of AI in precision medicine, improving computing power, and declining hardware cost), restraints (high implementation costs of AI limit adoption in biotechnology, especially for SMEs and emerging economies, data privacy risks and compliance challenges for AI in biotechnology), opportunities (integrating AI and big data in precision medicine for biotechnology advancement, surge in biotechnology investments enhances opportunities for AI to accelerate drug discovery innovations, innovation across healthcare, agriculture, and environmental science for global growth), and challenges (data quality and interpretability issues that hinder AI integration and trustworthiness, AI deployment in biotechnology hindered by talent shortages and evolving regulatory challenges) influencing the growth of the AI in biotechnology market.

  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the AI in biotechnology market.
  • Market Development: Comprehensive information on the lucrative emerging markets, by offering, function, deployment mode, end-user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the AI in biotechnology market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the AI in biotechnology market including NVIDIA Corporation (US), Illumina, Inc. (US), Exscientia (UK), Schrödinger, Inc. (US), Recursion Pharmaceuticals, Inc.  (US), SOPHiA GENETICS (Switzerland), Predictive Oncology. (US),Deep Genomics. (Canada), Exscientia (US), and Data4Cure, Inc.

医療・医薬の最新記事8件